[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Cowman et al., 2019 - Google Patents

Role of hyaluronan in inflammatory effects on human articular chondrocytes

Cowman et al., 2019

View HTML
Document ID
16951755052232693457
Author
Cowman M
Shortt C
Arora S
Fu Y
Villavieja J
Rathore J
Huang X
Rakshit T
Jung G
Kirsch T
Publication year
Publication venue
Inflammation

External Links

Snippet

Hyaluronan (HA) fragments have been proposed to elicit defensive or pro-inflammatory responses in many cell types. For articular chondrocytes in an inflammatory environment, studies have failed to reach consensus on the endogenous production or effects of added …
Continue reading at link.springer.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Similar Documents

Publication Publication Date Title
Cowman et al. Role of hyaluronan in inflammatory effects on human articular chondrocytes
Mohd Isa et al. Implantation of hyaluronic acid hydrogel prevents the pain phenotype in a rat model of intervertebral disc injury
Tan et al. Chondroitin-6-sulfate attenuates inflammatory responses in murine macrophages via suppression of NF-κB nuclear translocation
Jiang et al. Hyaluronan as an immune regulator in human diseases
Peters et al. Diverse roles for hyaluronan and hyaluronan receptors in the developing and adult nervous system
RU2508115C2 (en) Injection composition of polydeoxyribonucleotides for treating osteoarticular diseases
Ye et al. Phosphorylation and anti-tumor activity of exopolysaccharide from Lachnum YM120
Ke et al. Immunostimulatory and antiangiogenic activities of low molecular weight hyaluronic acid
Lan et al. Preparation of low-molecular-weight chondroitin sulfates by complex enzyme hydrolysis and their antioxidant activities
Nikolova et al. Characterization and potential antitumor effect of a heteropolysaccharide produced by the red alga Porphyridium sordidum
Chua et al. Synthetic xylosides: probing the glycosaminoglycan biosynthetic machinery for biomedical applications
Avenoso et al. Hyaluronan fragments produced during tissue injury: A signal amplifying the inflammatory response
Lundin et al. Circulating hyaluronate in psoriasis
Hoarau et al. Lung Hyaluronasome: Involvement of Low Molecular Weight Ha (Lmw-Ha) in Innate Immunity
Ruggiero et al. Is chondroitin sulfate responsible for the biological effects attributed to the GC protein-derived Macrophage Activating Factor (GcMAF)?
D'Ascola et al. Hyaluronan oligosaccharides modulate inflammatory response, NIS and thyreoglobulin expression in human thyrocytes
Venkatesan et al. Increased deposition of chondroitin/dermatan sulfate glycosaminoglycan and upregulation of β1, 3-glucuronosyltransferase I in pulmonary fibrosis
Yin et al. Unmasking Chemokine‐Inducing Specificity in Oligosaccharide Biomaterial to Promote Hair Growth
CN105246498A (en) Method for producing a mixture of neutral oligosaccharides extracted from flaxseed
He et al. Sulfated modification of hyaluronan tetrasaccharide enhances its antitumor activity on human lung adenocarcinoma A549 cells in vitro and in vivo
Warda et al. Is human placenta proteoglycan remodeling involved in pre-eclampsia?
Zhang et al. Interactions between nattokinase and heparin/GAGs
Asboe-Hansen et al. Mastocytosis (urticaria pigmentosa) with urinary excretion of hyaluronic acid and chondroitin sulfuric acid: changes induced by polymyxin B
CN111334468A (en) Application of low molecular weight hyaluronic acid fragments in inducing red blood cell string-shaped aggregation
JP5622346B2 (en) Neuronal cell death inhibitor, etc.